Brief: Amphastar Pharmaceuticals Inc Says On Nov 15, Co's Unit Entered Into A Supply Agreement With Nanjing Letop Biotechnology Co.
18/11/2022 21:54
Nov 18 (Reuters) - Amphastar Pharmaceuticals Inc
AMPH.O :
* AMPHASTAR PHARMACEUTICALS INC - ON NOVEMBER 15, CO'S UNIT
ENTERED INTO A SUPPLY AGREEMENT WITH NANJING LETOP BIOTECHNOLOGY
CO.
* AMPHASTAR PHARMACEUTICALS -PURSUANT TO DEAL, LETOP TO
MANUFACTURE, DELIVER CHEMICAL INTERMEDIATES FOR UNIT ACCORDING
TO REQUIREMENTS OF PURCHASE ORDERS
Further company coverage: AMPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amphastar Pharmaceuticals
See all newsAmphastar Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Amphastar Pharmaceuticals Q2 EPS USD 0.67
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending
U.S. STOCKS ON THE MOVE-Amkor Technology, Dynatrace, Corvex
Amphastar rises after FDA approves new over-the-counter overdose spray